Stock listing
0TB Stock Price, News, Filings & Events — Theravance Biopharma, Inc.
Selected listing: 0TB · DUS · EUR · DE
This page tracks Theravance Biopharma, Inc.'s 0TB:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0TB:DUS. 0TB:DUS is the stock-level entry point for investors researching Theravance Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Theravance Biopharma, Inc. (Ticker: TBPH) is a public company based in America, with a market capitalization of approximately $877.45 million. The company focuses on developing innovative therapies for various medical conditions. Its commitment to advancing biopharmaceutical solutions positions it as a key player in the healthcare sector.
- Ticker
- 0TB:DUS
- Asset type
- Stock
- Market cap
- $883.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- DUS
- Currency
- EUR
Theravance Biopharma, Inc. 0TB:DUS stock context
This page tracks Theravance Biopharma, Inc.'s 0TB:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0TB:DUS. 0TB:DUS is the stock-level entry point for investors researching Theravance Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Theravance Biopharma, Inc. (Ticker: TBPH) is a public company based in America, with a market capitalization of approximately $877.45 million. The company focuses on developing innovative therapies for various medical conditions. Its commitment to advancing biopharmaceutical solutions positions it as a key player in the healthcare sector.
Latest news from Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 10, 2026
THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT
June 29, 2026
Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 7, 2026
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 19, 2026
Theravance Biopharma Reports Phase 3 CYPRESS Study Did Not Meet Primary Endpoint; Board Accelerates Strategic Review and Announces Cost R...
March 3, 2026
Theravance Biopharma, Inc. earnings calls
Theravance Biopharma, Inc. (TBPH) Q1 2026 Earnings Call
December 8, 2025 · Replay with transcript and chapters
Theravance Biopharma, Inc. (TBPH) Q3 2025 Earnings Call
November 10, 2025 · Replay with transcript and chapters
Theravance Biopharma, Inc. (TBPH) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Theravance Biopharma, Inc. (TBPH) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Theravance Biopharma, Inc. (TBPH) Q4 2024 Earnings Call
February 26, 2025 · Replay with transcript and chapters
Theravance Biopharma, Inc. (TBPH) Q3 2024 Earnings Call
November 12, 2024 · Replay with transcript and chapters
Research Theravance Biopharma, Inc.
Theravance Biopharma, Inc. investor report
Review AI stock analysis and investor report context for 0TB:DUS.
Theravance Biopharma, Inc. company profile
View the public company page for Theravance Biopharma, Inc. on 6ix.
Theravance Biopharma, Inc. news
Read company news and market updates connected to Theravance Biopharma, Inc..
Theravance Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Theravance Biopharma, Inc..
Alternate listings
TBPH:NASDAQ
US · USD
Alternate listing for Theravance Biopharma, Inc.; the primary context on this page is 0TB:DUS.
0TB:GETTEX
DE · EUR
Alternate listing for Theravance Biopharma, Inc.; the primary context on this page is 0TB:DUS.
A1137V:LSX
DE · EUR
Alternate listing for Theravance Biopharma, Inc.; the primary context on this page is 0TB:DUS.
A1137V:LS
DE · EUR
Alternate listing for Theravance Biopharma, Inc.; the primary context on this page is 0TB:DUS.
TBPH:BOATS
US · USD
Alternate listing for Theravance Biopharma, Inc.; the primary context on this page is 0TB:DUS.
0TB:FWB
DE · EUR
Alternate listing for Theravance Biopharma, Inc.; the primary context on this page is 0TB:DUS.
0TB:SWB
DE · EUR
Alternate listing for Theravance Biopharma, Inc.; the primary context on this page is 0TB:DUS.
0TB:TRADEGATE
DE · EUR
Alternate listing for Theravance Biopharma, Inc.; the primary context on this page is 0TB:DUS.